NCT07516353 2026-04-08
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
Clinical Trials
10 trialsNCT07514819 2026-04-07
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
St. Jude Children's Research Hospital
Phase NA Not yet recruiting
NCT07466316 2026-03-12
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Children's Oncology Group
Phase 3 Not yet recruiting
NCT07444918 2026-03-03
Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07355855 2026-01-21
A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
Fudan University
Phase 2 Not yet recruiting
NCT07054944 2025-12-15
T-LyM
University of Rochester
Phase 1 Not yet recruiting
NCT07224568 2025-11-04
INTERCEPT
Seattle Children's Hospital
Phase 1 Not yet recruiting
NCT06932861 2025-04-22
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Chinese PLA General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06822842 2025-02-12
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not yet recruiting
NCT06029465 2023-09-08
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting